| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1172: Atogepant for treating migraine |
|
Medicine details |
|
| Medicine name | atogepant (Aquipta®) |
| Formulation | oral tablets |
| Reference number | 7721 |
| Indication | Acute treatment of migraine with or without aura in adults |
| Company | AbbVie Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 19/05/2026 |
| NICE guidance | |